Overview
For over 30 years, the Acute Leukemia Forum (ALF) has continued its tradition of being a premier event for hematology and oncology professionals. This conference brings together leading experts to share groundbreaking research and clinical advances that shape the treatment and management of acute leukemia and myelodysplastic syndromes. As we look ahead to 2027, ALF will focus on addressing the evolving educational needs of those involved in the care of patients with these challenging malignancies.
We look forward to you joining our community of healing at the 31st Acute Leukemia Forum, April 15-16, 2027, at the Hilton La Jolla Torrey Pines, La Jolla, California!
Meet the Chairs
Daniel A. Pollyea, MD, MS
Professor of Medicine Clinical Director of Leukemia Services Associate Chief of Clinical Affairs Robert H. Allen MD Chair in Hematology Research Division of Hematology University of Colorado School of Medicine Aurora, Colorado
Eytan M. Stein, MD
Chief, Leukemia Service Director Program for Drug Development in Leukemia Associate Attending Physician Department of Medicine Memorial Sloan Kettering Cancer Center New York, New York
Hetty E. Carraway, MD, MBA
Professor of Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University Director, Leukemia Program Vice Chair Strategy and Enterprise Development Taussig Cancer Institute Cleveland Clinic Cleveland, Ohio